Kristyn Elizabeth Anthony, MD | |
19185 Sw 90th Ave, Tualatin, OR 97062-7558 | |
(503) 813-2000 | |
Not Available |
Full Name | Kristyn Elizabeth Anthony |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 19185 Sw 90th Ave, Tualatin, Oregon |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326364753 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 171413 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kristyn Elizabeth Anthony, MD 19185 Sw 90th Ave, Tualatin, OR 97062-7558 Ph: (503) 813-2000 | Kristyn Elizabeth Anthony, MD 19185 Sw 90th Ave, Tualatin, OR 97062-7558 Ph: (503) 813-2000 |
News Archive
In this post in the Results for Development Institute's "Center for Global Health R&D Policy Assessment" blog, Aarthi Rao, a program officer at the institute, examines whether corporate social responsibility (CSR) programs within Indian pharmaceutical companies can help fight neglected diseases.
The Bill & Melinda Gates Foundation's "Impatient Optimists" blog features "a Q&A between Julia Bluestone of Jhpiego and the Frontline Health Workers Coalition and Dr. Henry Perry of the Johns Hopkins Bloomberg School of Public Health on a recently released report examining community health workers' effectiveness in saving lives and improving health."
Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.
While the health risks associated with indoor secondhand smoke are well documented, little research has been done on exposure to toxic tobacco fumes outdoors.
Multiple myeloma is an incurable cancer of the bone marrow. To date, no screening systems have been available to examine the effects of new drugs in a 3D environment. Researchers on the EU project OPTATIO might now fill this gap. They succeeded in growing miniature human myelomas in shell-less chicken eggs in order to screen new marine compounds for anti-myeloma activity.
› Verified 6 days ago